Bengaluru, January 22, 2026: Strengthening its position as one of Bengaluru’s leading multi-specialty hospital networks, SPARSH Group of Hospitals has launched a state-of-the-art Bone Marrow Transplant (BMT) Unit at its Hennur Road facility. With cancer and complex blood disorder cases rising across Karnataka, the new unit enhances access to advanced, life-saving treatments for patients from Bengaluru, South India, and overseas.
The dedicated BMT unit will provide comprehensive care for complex haematological conditions including leukemia, thalassemia, lymphoma, aplastic anemia, and other blood disorders, bringing world-class clinical expertise closer to home.
The unit was inaugurated by Dr. Sharan Shivaraj Patil, Chairman & Chief Orthopaedic Surgeon, SPARSH Group of Hospitals, in the presence of Mr. Jasdeep Singh, Group CEO, senior clinicians, and healthcare leaders. The launch event also witnessed the presence of BMT survivors patients who have successfully undergone transplants at SPARSH Hospitals who shared their journeys of courage, recovery, and renewed life.
Speaking on the occasion, Dr. Sharan Shivaraj Patil said, “Every life deserves a stronger second chance. The launch of this Bone Marrow Transplant Unit marks a deeply meaningful milestone for SPARSH. For patients and families facing some of the most challenging diagnoses, this represents renewed hope, driven by clinical excellence, advanced technology, and compassionate, end-to-end care.”
The Bone Marrow Transplant Unit is a key pillar of the SPARSH Institute of Cancer Care, the group’s integrated oncology platform delivering end-to-end cancer care, from early diagnosis and precision treatment to advanced therapies and long-term survivorship, through multidisciplinary expertise and patient-centric care pathways.
The advanced BMT wing features HEPA-filtered isolation rooms, a dedicated blood bank, stem cell processing facilities, and in-house testing for HLA typing, infections, and drug-level monitoring. The unit is supported by an experienced multidisciplinary team of haemato-oncologists, BMT physicians, intensivists, and specially trained nursing staff. In addition to conventional transplant procedures, the unit is equipped to offer CAR-T Cell Therapy and advanced immunotherapy, further strengthening SPARSH Hospitals’ oncology and haematology care ecosystem.
With this launch, SPARSH Group of Hospitals continues to expand its advanced clinical capabilities, reaffirming its commitment to accessible, high-quality, patient-centric care.
